Concepedia

Hans Matter

HM

Statistics

Publications

76

Citations

4.3K

H-Index

36

Active since

1991

Affiliations

Sanofi (Germany)(Current)

Sanofi (France)

Technical University of Munich

LETI Pharma (Germany)

University of Würzburg

Hans Matter is an author at Sanofi (Germany) specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

1991–2023

76

Publications

76

Targeting DnaN for tuberculosis therapy using novel griselimycins

Angela Kling, Peer Lukat, Deepak V. Almeida et al. · Science · 2015 · 313 citations

, , +16

Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity

Hans Matter, Marc Nazaré, Stefan Güssregen et al. · Angewandte Chemie International Edition · 2009 · 270 citations

, , +17

Selecting Optimally Diverse Compounds from Structure Databases:  A Validation Study of Two-Dimensional and Three-Dimensional Molecular Descriptors

Hans Matter · Journal of Medicinal Chemistry · 1997 · 251 citations

, , +17

Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets

Jan Wenzel, Hans Matter, Friedemann Schmidt · Journal of Chemical Information and Modeling · 2019 · 220 citations

, , +17

Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors:  Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols

Andreas Evers, Hans Matter, Thomas Klabunde · Journal of Medicinal Chemistry · 2005 · 183 citations

, , +17

1–5 of 76